Viewing Study NCT06388759


Ignite Creation Date: 2025-12-24 @ 2:56 PM
Ignite Modification Date: 2025-12-27 @ 2:05 PM
Study NCT ID: NCT06388759
Status: TERMINATED
Last Update Posted: 2025-08-29
First Post: 2024-04-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: TQ05105 Tablet for Myelofibrosis Treatment in Ruxolitinib-Resistant or Intolerant Patients
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module